TNDM: Kyrillos Jean-Claude reports an option exercise and tax withholding on shares
By AlphaYouPublished Form 4
Kyrillos Jean-Claude
Reporting filer
Kyrillos Jean-Claude reports an option exercise and tax withholding on shares, not an open-market purchase or sale, in Tandem Diabetes Care Inc. Form 4 filed Oct 19, 2026 lists 3 entries.
- Disclosed
- Oct 19, 2026
Reported details
3 entries| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Kyrillos Jean-Claude | 2026-10-15 | M | Exercise or conversion | 3637 | 0 | 33,927 | 4 days | Filed terms
|
| Common Stock | Kyrillos Jean-Claude | 2026-10-15 | F | Tax/exercise withholding | 1926 | 16.52 | 32,001 | 4 days | Filed terms
|
| Restricted Stock Unit (derivative) | Kyrillos Jean-Claude | 2026-10-15 | M | Exercise or conversion | 3637 | 0 | 10,908 | 4 days | Filed terms
|
Common Stock
- Owner
- Kyrillos Jean-Claude
- Date
- 2026-10-15
- Code
- M
- Action
- Exercise or conversion
- Quantity
- 3637
- Price
- 0
- Following holdings
- 33,927
- Reporting delay
- 4 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-10-15
- transaction Form Type: 4
- transaction Code: M
- equity Swap Involved: 0
- transaction Shares: 3637
- transaction Price Per Share: 0
- transaction Acquired Disposed Code: A
- shares Owned Following Transaction: 33927
- direct Or Indirect Ownership: D
Common Stock
- Owner
- Kyrillos Jean-Claude
- Date
- 2026-10-15
- Code
- F
- Action
- Tax/exercise withholding
- Quantity
- 1926
- Price
- 16.52
- Following holdings
- 32,001
- Reporting delay
- 4 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-10-15
- transaction Form Type: 4
- transaction Code: F
- equity Swap Involved: 0
- id: F1
- transaction Shares: 1926
- transaction Price Per Share: 16.52
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 32001
- direct Or Indirect Ownership: D
Restricted Stock Unit (derivative)
- Owner
- Kyrillos Jean-Claude
- Date
- 2026-10-15
- Code
- M
- Action
- Exercise or conversion
- Quantity
- 3637
- Price
- 0
- Following holdings
- 10,908
- Reporting delay
- 4 days
- Filed terms and references
Filed terms
- security Title: Restricted Stock Unit
- id: F2
- id: F3
- transaction Date: 2026-10-15
- transaction Form Type: 4
- transaction Code: M
- equity Swap Involved: 0
- transaction Shares: 3637
- transaction Price Per Share: 0
- transaction Acquired Disposed Code: D
- id: F4
- id: F4
- underlying Security Title: Common Stock
- underlying Security Shares: 3637
- shares Owned Following Transaction: 10908
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Kyrillos Jean-Claude: EVP & Chief Operating Officer.
- F1: Shares withheld by the Issuer to satisfy tax withholding requirements upon the vesting of restricted stock units (RSUs). No shares were sold.
- F2: Awarded on July 15, 2024 pursuant to the Tandem Diabetes Care Inc. 2023 Long-Term Incentive Plan, as amended, and agreements related thereto (the 2023 Plan).
- F3: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan.
- F4: One-third of the RSUs granted on July 15, 2024 vested on July 15, 2025, with the remaining RSUs vesting in eight (8) equal quarterly installments thereafter, subject to the terms of the 2023 Plan.
Original sources
Prepared automatically from public filing data. Report a correction.